BioSpace News Archive

The US Food and Drug Administration has approved the use of iTFlow® in blood flow analysis.

Endospan , a pioneer in endovascular repair of aortic arch disease, announces the initial experience with its custom-made NEXUS DUO™ Aortic Arch Stent Graft System.

Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”) today announces that data from POSEIDON, its North American pivotal study of the alfapump will be presented during two poster sessions at the EASL Congress 2023, taking place in Vienna, Austria from 21 to 24 June 2023.

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Memorandum of Understanding (MoU) with AbbVie Biopharmaceutical and M42 to elevate collaborative efforts in tailoring personalised medicine and genomics in Abu Dhabi, the capital of the United Arab Emirates (UAE).

AWAK Technologies (AWAK) and Singapore General Hospital (SGH) announce the launch of a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device.

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced it has received regulatory approval from the Maryland Cannabis Administration (MCA) for the acquisition previously announced on June 8, 2023, of Derby 1, LLC (d/b/a “Peninsula Alternative Health”), a medical dispensary in Maryland.

Beactica Therapeutics AB, the Swedish precision oncology company, announced the appointment of Jarl Ulf Jungnelius M.D. to its Board of Directors.

Sensorion announces promising preliminary results from its Proof of Concept Phase 2a clinical trial of SENS-401 for residual hearing preservation following cochlear implantation.

Allgenesis Biotherapeutics Inc. announced topline data from the company’s Phase 1b clinical trial for AG-80308, a first-in-class, formyl peptide receptor agonist formulated as an aqueous solution eye drop for the treatment of Dry Eye Disease.

Gene Biotechnology Enterprises Ltd., also known as Gene Bio Medical, is excited to announce its strategic partnership with the Canadian Hub for Health Intelligence & Innovation in Infectious Diseases.